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Cystic fibrosis (CF) patients suffer from chronic bacterial lung infections that lead to death in the
majority of cases. The need to maintain lung function in these patients means that characterising
these infections is vital. Increasingly, culture-independent analyses are expanding the number of
bacterial species associated with CF respiratory samples; however, the potential significance of
these species is not known. Here, we applied ecological statistical tools to such culture-independent
data, in a novel manner, to partition taxa within the metacommunity into core and satellite species.
Sputa and clinical data were obtained from 14 clinically stable adult CF patients. Fourteen rRNA
gene libraries were constructed with 35 genera and 82 taxa, identified in 2139 bacterial clones.
Shannon–Wiener and taxa-richness analyses confirmed no undersampling of bacterial diversity.
By decomposing the distribution using the ratio of variance to the mean taxon abundance,
we partitioned objectively the species abundance distribution into core and satellite species. The
satellite group comprised 67 bacterial taxa from 33 genera and the core group, 15 taxa from 7 genera
(including Pseudomonas (1 taxon), Streptococcus (2), Neisseria (2), Catonella (1), Porphyromonas
(1), Prevotella (5) and Veillonella (3)], the last four being anaerobes). The core group was dominated
by Pseudomonas aeruginosa. Other recognised CF pathogens were rare. Mantel and partial Mantel
tests assessed which clinical factors influenced the composition observed. CF transmembrane
conductance regulator genotype and antibiotic treatment correlated with all core taxa. Lung function
correlated with richness. The clinical significance of these core and satellite species findings in the
CF lung is discussed.
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Introduction
Cystic fibrosis (CF) is an autosomal genetic disorder
affecting more than 8500 patients in the United
Kingdom alone (Anon, 2009). Although this genetic
disorder affects many body systems, its impact on
the lungs of CF patients is the most clinically
significant. Here, the genetic defect results in the
absence or abnormal functioning of the CF trans-
membrane conductance regulator (CFTR) protein,
involved in ion transfer across epithelial cell
surfaces. In the lower airways, this leads to an
increased viscosity of airway secretions and, in turn,
an impaired mucociliary clearance of material
entering the lungs (Clunes and Boucher, 2007;
Coakley and Boucher, 2007). Together, these factors
make the CF lower airways a favourable anatomical
niche for bacterial persistence. Exposure to a diverse
range of bacterial species, through constant venti-
lation and close proximity to the communities
of the upper respiratory tract and oral cavity, rapidly
results in the establishment of a diverse bacterial
community (Rogers et al., 2005). The damage
that results from the inflammatory response to the
presence of bacteria in the lower airways is the
primary cause of morbidity and mortality for CF
patients (Balfour–Lynn and Elborn, 2007), and
despite substantial improvements in treatment, the
predicted survival of UK CF patients is 35.2 years
(Anon, 2009). Achieving a better understanding of
the way in which infective bacterial communities in
the CF lower airways are organised is, therefore,
of utmost clinical importance. Further, the large
CF patient group, along with the ability to sample
non-invasive and well-defined treatment condi-
tions, makes CF lung infections an ideal model
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chronic respiratory infections more generally. The
importance of this is emphasised further, given that
respiratory illness is one of the leading global causes
of human morbidity and mortality (Mathers et al.,
2006).
Traditionally, the microbiological analyses of
clinical specimens have relied on cultivation before
identification, where routine screening of CF
sputum samples has typically focused on only a
few bacterial species, including Pseudomonas
aeruginosa, Burkholderia cepacia complex,
Haemophilus influenzae, Staphylococcus aureus,
Moraxella catarrhalis and Streptococcus pneumo-
niae (Anon, 2008). Increasingly though, approaches
and methods developed to address environmental
microbiological questions are being adopted to
study CF respiratory microbiology (Rogers et al.,
2003; Sibley et al., 2008). The adoption of culture-
independent methodologies has, perhaps unsurpris-
ingly, revealed the presence of much more complex
bacterial communities than previously realised
(Rogers et al., 2005, 2009). In detail though, such
studies have shown a greater diversity of anaerobic
and aerobic species as present in CF sputa and,
importantly, the probable presence of species from
the oral cavity that may represent new candidate
pathogens (Rogers et al., 2006; Harris et al., 2007;
Sibley et al., 2008). There is, therefore, now a
pressing need to distinguish between those newly
reported species that are true colonisers of the CF
lower airways, and as such of potential clinical
importance, and those introduced to the airways
that are only present transiently.
Work on CF respiratory microbiology has also led
to the proposal of other important concepts.
Extending from observations of bacterial diversity
in the CF lower airways, these infections have
recently been proposed to be driven by communities
of interacting organisms (Rogers et al., 2010a). As
such, the chronically colonised CF airways repre-
sent a previously unrealised complex and diverse
ecosystem (Harrison, 2007). More than this though,
the advantages in structuring subsequent research
within an ecological framework are clear. Two recent
studies of CF respiratory microbiology have notably
coupled environmental microbiological approaches
with community ecological analyses (Kelpac-Ceraj
et al., 2010; Rogers et al., 2010b). Based on species–
time relationships, Rogers et al. (2010b) demon-
strated that reliance on a single respiratory sample
was insufficient for the detection of recognised
CF pathogens. Kelpac-Ceraj et al. (2010) studied
bacteria sampled from a paediatric CF patient
cohort, and suggested that community composition
may well be a better predictor of disease progression
than the traditional approach of tracking particular
recognised CF pathogens.
Both these strands argue strongly for the need
to introduce relevant ecological approaches, with
biodiversity being the first term to consider. Hubbell
(2001) defined biodiversity as being synonymous
with species richness and relative species abun-
dance in space and time, where relative species
abundance refers to the commonness or rarity of
a species in relation to other species in a given
community. As such, the question of what makes a
species common or rare has long been of empirical
and theoretical interest in community ecology
(Preston, 1948; Hubbell, 2001). There is also a long
tradition in ecology, whereby species in spatially
separated sites can be divided into core and satellite
groups at smaller ecological scales (Hanski, 1982,
1999; Ulrich and Zalewski, 2006). Here, the former
group comprises species that are widely distributed
and typically abundant within local sites and the
latter group consists mostly of rare species occurring
in low abundance at a limited number of sites. This
distinction between frequent and occasional species
groups has long been discussed in a metapopulation
context (Ulrich and Zalewski, 2006). However, the
core–satellite species distinction has been more
recently extended to metacommunities, in terms of
either spatial (site occupancy) or temporal (persis-
tence) distributions (Magurran and Henderson,
2003; Ulrich and Ollik, 2004; Ulrich and Zalewski,
2006).
Using a 21-year time-series data set, Magurran and
Henderson (2003) investigated the relative species
abundance of fish species from Hinkley Point in the
Bristol Channel (UK). They determined that the
behaviour of species, in terms of their permanence
in the sampling record, affected their signature on
the empirical species abundance distribution (SAD)
(Magurran and Henderson, 2003; Magurran, 2007).
They found that the satellite species were typically
rare and in low abundance when they did occur
and the core species, fish that were commonly
recorded year after year, had higher abundances.
The temporal metacommunity was readily divided
into two categories, where core species followed a
log-normal distribution, whereas the SAD for the
satellite species resembled a log-series distribution.
Furthermore, they noted that the two groups of
species had differing ecological characteristics; core
species were typically adapted to life in estuarine
habitats, whereas satellite species were better
suited to life in other habitats such as deep water
(Magurran and Henderson, 2003; Magurran, 2007).
Ulrich and Zalewski (2006), in a spatial study of
ground beetles on small lake islands in Poland, also
found that the beetle metacommunity SAD could
be partitioned into core and satellite species.
They concluded that the division was not a
sampling artefact but reflected life history strategies,
as species differed in their spatial distribution and
body size ratios. Both studies demonstrated that
biological factors underpinned the relative abun-
dance of the core species, whereas random dispersal
was more important in structuring the satellite
species (Magurran and Henderson, 2003; Ulrich
and Zalewski, 2006; Magurran, 2007). These and
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2005; Dolan et al., 2009) have strengthened the
proposal that a community comprises core and
satellite species, and that partitioning the two
groups from a (spatial or temporal) metacommunity
reveals important aspects of SADs, which would
otherwise be neglected without such a distinction.
Furthermore, both Gray et al. (2005) and Magurran
and Henderson (2003) have advocated that a two-
group model is the most parsimonious way to deal
with empirical SADs.
In the current study, we applied the two-group
core–satellite modelling approach to the bacterial
communities present in respiratory samples from
a cohort of 14 CF adult patients, in order to address
the following aims: (1) establish whether the ‘tradi-
tionally’ recognised CF pathogens were part of
the core species group or, alternatively, were
randomly dispersed throughout the patients
sampled; (2) determine how species, regarded as
belonging to the human oral cavity, were distributed
between the two groups; and (3) ascertain how
anaerobic and aerobic species were distributed
throughout the empirical SAD. These findings then
allowed the determination of which clinical factors
correlated with community characteristics, such as
richness and composition, as applied for the whole
community and the core and satellite species
groups derived.
Materials and methods
Spontaneously expectorated sputum samples were
collected from 14 adult CF patients attending the
Adult CF Clinic at the Southampton General
Hospital, under full ethics approval (Southampton
and South West Hampshire Research Ethics
Committee (06/Q1704/26)). At the time of sampling,
all patients were clinically stable and had not
received any antibiotic therapy in the 14 days before
enrolment. Clinical parameters, including lung
function (forced expiratory volume (litres) in 1s),
CF genotype, recent antibiotic history, temperature,
patient-reported measures of cough severity, sputum
productivity, breathlessness and general well-being,
were recorded at the time of samples collection
(Table 1).
All sputum samples were collected in sterile
containers, placed on ice and transported to the
microbiology laboratory within 60min. Samples
were then frozen and stored at  801C before
analysis. Before DNA extraction, sputum samples
were washed three times in 0.9% phosphate-
buffered saline to remove adherent saliva. The
DNA extraction was performed as previously des-
cribed by Rogers et al. (2004). 16S rRNA genes were
amplified by PCR using primers, Bact-7F (50-AGAG
TTTGATYMTGGCTCAG-30) and Bact-1510R (50-AC
GGYTACCTTGTTACGACTT-30), as previously des-
cribed (Stecher et al., 2007). The amplification
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The ISME Journalproducts were essentially full-length 16S rRNA
genes, ranging from 1202 to 1517 in length, with a
median length of 1475 base pairs.
Clone library construction and sequencing were
carried out as described previously (Stecher et al.,
2007). Colonies were randomly selected for sequen-
cing from agar plates for each patient. Sequences
were aligned using the NAST aligner (DeSantis
et al., 2006) and these alignments were subject
to extensive manual curation using the ARB package
(Ludwig et al., 2004) before further analysis.
Sequences were tested for chimeras with Mallard
(Ashelford et al., 2006), Bellerophon at Greengenes
(DeSantis et al., 2006) and Pintail (Ashelford et al.,
2005) and any sequence that appeared to be
chimeric was removed. After removal of chimeras
and other suspect sequences, the remaining
sequences (deposited in GenBank under accession
numbers FM995625–FM997761) were initially given
a broad classification to the phylum level using the
Classifier tool at the RDPII website (Wang et al.,
2007). To obtain more detailed taxonomic informa-
tion, the sequences were divided into phylotypes.
Distance matrices were then entered into the
DOTUR program (Schloss and Handelsman, 2005)
set to the furthest neighbour and 99%-similarity
setting. The resulting phylotypes were then
assigned similarities to nearest neighbours using
MegaBLAST.
Two complementary measurements of diversity
were used to determine whether the clone sample
sizes were large enough to effectively assess the
diversity of the bacteria in each of the sputum
samples taken, as previously described (Lilley et al.,
1996). The indices used were the Shannon–Wiener
index (H0) and species richness (S*). H 0 is a
combined figure that reflects the extent of diversity
and the evenness of isolate distribution between
taxa. It is sensitive to changes in the frequency of
common and less common (though not the rarer)
species. S* is simply the number of species in a
sample. Differences in H0 and S* were tested using
the method of Solow (1993), which employs a
randomisation test as follows: the clones derived
from two samples (A and B) are listed, the chosen
population parameter (for example, H0) calculated
and the difference in parameters for the two samples
noted (DA–B¼H0
A H0
B) (Solow, 1993). The clones in
the two samples are then amalgamated, randomly
mixed and repartitioned to the original sample sizes,
the population parameter recalculated and a new
difference noted. This random mixing, repartition-
ing and calculation of the difference are repeated
1000 times and the values (D1–D1000) ranked. Finally,
to test whether H0
A and H0
B are significantly different
at the 95% confidence level, DA–B is compared with
the ranked values. If this difference is greater than
or equal to the value of the difference at the
97.5 percentile, or less than or equal to the value
of the difference at the 2.5 percentile, then the
values for the parameter of the two samples are
considered significantly different. An Excel macro-
program was written to apply the Solow’s method
to the pair-wise comparison of each of the two
parameters (S* and H0).
The log-series and log-normal models were fitted to
the data, as previously described (Magurran, 2004).
Likewise, the w
2 and Kolmogorov–Smirnov goodness-
of-fit tests were performed as described by Magurran
(2004). Poisson distribution tests were carried out
according to the method described by Krebs (1999).
Regression analysis, coefficients of determination
(r
2), residuals and significance (P) were calculated
using Minitab software (version 14.20, Minitab,
University Park, PA, USA). The Bray–Curtis (quanti-
tative) index of similarity and subsequent average
linkage clustering of community profiles were per-
formed using the PAST (Palaeontological Statistics,
version 1.90) program available from the University
of Oslo website link (http://folk.uio.no/ohammer/
past) run by Øyvind Hammer. Mantel and partial
Mantel tests were performed, as previously described
(Green et al., 2004), using the XLSTAT (version 2006,
Addinsoft, Paris, France) program.
Results and discussion
A total of 2139 bacterial clones, comprising 35
genera and 82 taxa, were generated from sputum
samples taken from 14 adult CF patients (Table 2).
To test whether clone sample sizes per patient were
sufficiently large to compare enough of the bacterial
diversity in CF patient airways, we used a rando-
mised re-sampling method using two indices of
diversity (Shannon–Wiener index (H0) and taxa
richness (S*)) (Supplementary Figure S1). These
analyses provided confirmation that sufficiently
large samples had been collected and bacterial
diversity was not undersampled.
Positive relationships between mean abundance
and distribution (number of sites occupied) have
been observed at many spatial scales for taxa when
classified into different types of ecological organisa-
tion (for example, guild or community) (Guo et al.,
2000). Within the current study, we also observed a
significant positive distribution–abundance rela-
tionship (Figure 1). This indicated that the bacterial
taxa that were widely distributed throughout the CF
airways sampled were more locally abundant than
the taxa with a more restricted distribution. There-
fore, as has been noted in studies of animal species,
the commonness and rarity of bacterial taxa in the
CF airway metacommunity were found to be related
to their permanence (Magurran and Henderson,
2003).
Magurran and Henderson (2003) previously parti-
tioned their empirical fish SAD into two groups of
persistent/abundant core species and infrequent/
less abundant satellite species by searching for a
discontinuity in the SAD. Here, we used an
alternative method proposed by those authors as a
Cystic fibrosis lung metacommunity ecology
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The ISME JournalTable 2 Bacterial taxa sampled from the lungs of the 14 cystic fibrosis patients
Class Family Taxon name Code
Actinobacteria Actinomycetaceae Actinomyces graevenitzii (98%) S, Ae, O
Actinomyces lingnae (98%) S, Ae, O
Actinomyces naeslundii S, Ae, O
Actinomyces naeslundii/viscosus (98%) S, Ae, O
Micrococcineae Rothia dentocariosa (97%) S, Ae, O
Rothia mucilaginosa S, Ae, O
Bacteroides Bacteroidaceae Bacteroides acidofaciens (88%) S, An
Bacteroides eggerthii (88%) S, An
Bacteroides uniformis (87%) S, An
Bacteroides uniformis (88%) S, An
Bacteroides viscericola (86%) S, An
Porphyromonadaceae Porphyromonas catoniae (92%) C, An, O
Tannerella forsythensis (94%) S, An, O
Prevotellaceae Prevotella loescheii (98%) S, An, O
Prevotella melaninogenica C, An, O
Prevotella nanceiensis S, An
Prevotella nigrescens S, An, O
Prevotella oris (98%) C, An, O
Prevotella oulora S, An, O
Prevotella pallens S, An, O
Prevotella pleuritidis S, An
Prevotella salivae C, An, O
Prevotella tannerae C, An, O
Prevotella veroralis C, An, O
Rikenellaceae Alistipes shahii (82%) S, An, O
Flavobacteria Flavobacteriaceae Capnocytophaga gingivalis S, Ae, O
Capnocytophaga granulosa (98%) S, Ae, O
Capnocytophaga leadbetteri (98%) S, Ae, O
Capnocytophaga sputigena S, Ae, O
Bacilli Staphylococcaceae Gemella haemolysans S, Ae, O
Staphylococcus aureus S, Ae
Aerococcaceae Abiotrophia defectiva S, Ae, O
Carnobacteriaceae Granulicatella adiacens S, Ae, O
Granulicatella para-adiacens S, Ae, O
Streptococcaceae Streptococcus infantis S, Ae, O
Streptococcus intermedius/constellatus S, Ae, O
Streptococcus mitis S, Ae, O
Streptococcus mitis/pneumoniae C, Ae, O
Streptococcus oralis S, Ae, O
Streptococcus parasanguis C, Ae, O
Streptococcus parasanguis/oralis/mitis S, Ae, O
Streptococcus pneumoniae S, Ae
Streptococcus salivarius S, Ae, O
Streptococcus salivarius/vestibularis/thermophilus S, Ae, O
Streptococcus sanguinis S, Ae, O
Clostridia Clostridiaceae Clostridium metallolevans (98%) S, Ae
Eubacteriaceae Mogibacterium neglectum S, Ae, O
Lachnospiraceae Catonella morbi (98%) C, An, O
Dorea longicatena S, An
Eubacterium sp. ‘Smarlab BioMol-2301166’ S, An
Eubacterium sp. ‘Smarlab BioMol-2301231’ S, An
Oribacterium sinus (98%) S, An
Butyrate-producer SR1/1 (97%) S, An
Veillonellaceae Veillonella atypica C, An, O
Veillonella dispar C, An, O
Veillonella parvula C, An, O
Veillonella ratti (96%) S, An, O
Dialister invisus S, An, O
Megasphaera micronuciformis S, An, O
Selenomonas infelix S, An, O
Fusobacteria Fusobacteriaceae Fusobacterium naviforme/nucleatum S, An, O
Fusobacterium nucleatum S, An, O
Leptotrichia trevisanii (97%) S, An, O
Betaproteobacteria Alcaligenaceae Achromobacter xylosoxidans/insolitus S, Ae
Neisseriales Eikenella corrodens S, Ae, O
Neisseria cinerea C, Ae, O
Neisseria elongata S, Ae, O
Neisseria flava/sicca/mucosa/pharyngis C, Ae, O
Neisseria flavescens (98%) S, Ae, O
Cystic fibrosis lung metacommunity ecology
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The ISME Journalway of objectively dividing empirical SAD into the
two species groups. Specifically, we chose to first
decompose the overall distribution using the ratio of
variance to the mean abundance for each bacterial
taxon; as such, this approach provides a tractable
and objective solution to partitioning a SAD into
two groups of core and satellite species (Magurran
and Henderson, 2003). The variance to mean ratio,
or index of dispersion, is an index used to model
whether the species follows a Poisson distribution,
falling between the 2.5 and 97.5% confidence limits
of the w
2 distribution (Krebs, 1999). Plotting the
indices of dispersion against persistence throughout
the CF airways sampled, 14 bacterial taxa were
randomly distributed through space, that is, those
taxa that fall below the 2.5% confidence limit line
(Figure 1). Bacterial taxa that occurred only in a
single patient were excluded from this analysis, as
their dispersion in space would have no variance.
However, following Fisher’s logic, 53 taxa would be
included in the log-series distribution (Fisher et al.,
1943). For the purpose of the current study, those
67 taxa that were randomly distributed were class-
ified as satellite species and the remaining 15 non-
randomly distributed taxa were classified as core
taxa, in the CF bacterial metacommunity (see Table 2
for core and satellite taxa identification).
Following categorisation of the CF bacterial
taxa into the two groups, the satellite taxa data
were fitted with the log-series distribution model,
whereas the core group was fitted with the
log-normal distribution model (Figure 2). Both the
w
2 and Kolmogorov–Smirnov goodness-of-fit tests
were employed to evaluate whether the observed
distributions were not significantly different from
the expected distributions; for example, if P40.05
for both tests, then a fit could be assumed. For fitting
of the log-series model to the satellite taxa, the
Kolmogorov–Smirnov test statistic was D¼0.072,
whereas the approximate critical value at the
Po0.05 level was greater, D0.05¼0.109. Similarly,
for fitting the log normal to the core group, the
values obtained were D¼0.152 and D0.05¼0.230. In
addition, for both the log-series and -normal model
fits, the w
2 values were not significantly different at
Table 2 (Continued)
Class Family Taxon name Code
Neisseria meningitidis (95%) S, Ae, O
Neisseria meningitidis (98%) S, Ae, O
Epsilonproteobacteria Campylobacteraceae Campylobacter concisus S, Ae, O
Campylobacter gracilis S, Ae, O
Gammaproteobacteria Altermonadaceae Alishewanella fetalis S, Ae
Pastuerellaceae Haemophilus haemolyticus (98%) S, Ae, O
Haemophilus influenzae S, Ae, O
Haemophilus parahaemolyticus S, Ae
Haemophilus parainfluenzae (97%) S, Ae
Terrahaemophilus aromaticivorans S, An
Moraxellaceae Acinetobacter lwoffii S, Ae
Pseudomonadaceae Pseudomonas aeruginosa C, Ae
Xanthomonadaceae Stenotrophomonas maltophilia S, Ae
Abbreviations: C, core group taxon; S, satellite group; Ae, aerobe; An, anaerobe; O, taxa associated with the oral microbiota.
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Figure 1 Distribution and dispersal of bacterial taxa across
patients. (a) The number of patients for whom each bacterial
taxon was observed, plotted against the mean abundance
(log10 scale) across all patients (r
2¼0.44; F1,80¼62.2; Po0.0001).
(b) Random and non-random dispersal through space visualised
by decomposing the overall distribution using an index of
dispersion based on the ratio of variance to the mean abundance
for each bacterial taxon from the 14 patients sampled. The line
depicts the 2.5% confidence limit for the w
2 distribution. The
97.5% confidence limit was not plotted, as no taxon fell below
that line.
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The ISME Journalthe Po0.05 level (Figure 2). Therefore, as the
observed distributions were not significantly differ-
ent from the expected, the log-series and -normal
models that had been fitted, respectively, to the
satellite and core groups could be accepted. Con-
versely, no good fit was obtained for the overall
empirical SAD by either of the two models (Po0.05
in each case for both types of goodness-of-fit tests). It
has been generally accepted that empirical SADs for
large communities of animal or plant species tend
towards the log normal (Preston, 1948; Gaston and
Blackburn, 2000; Magurran and Henderson, 2003).
However, this view has begun to change, as increas-
ing lines of evidence have demonstrated that
large communities are typically characterised by
an excess of rare species, resulting in a negatively
skewed distribution (Gaston and Blackburn, 2000;
Hubbell, 2001; Magurran, 2004). Despite the CF
metacommunity investigated here having only rela-
tively low bacterial diversity compared with other
systems such as soil, when the distribution for all
CF bacterial taxa was plotted (Figure 2), or rather
when the core and satellite group distributions were
superimposed, a negatively skewed distribution
characterised by rare taxa was the result.
The satellite group comprised 67 different
bacterial taxa from 33 genera and accounted for
only 11.1% of the total abundance (Table 2). From
the satellite taxa, only 53 taxa were sampled from
one individual patient. In contrast, the core group
comprised 15 taxa from 7 genera (including Cato-
nella (1 taxon), Neisseria (2), Porphyromonas
(1), Prevotella (5), Pseudomonas (1), Streptococcus
(2) and Veillonella (3)), accounting for 88.9% of the
total abundance (Table 2). The core group was
dominated by one taxon, P. aeruginosa, considered
previously to be the predominant CF respiratory
pathogen. This accounted for 70.6% of the total
abundance and was found in all patients (except
patient 1 (P1)) (Figure 3). With regard to the
distribution of other recognised and candidate CF
pathogens, the five recorded pathogens were
randomly distributed throughout the patients and
were therefore assigned to the satellite taxa group.
Each of these CF pathogens was found only in low
abundance and in single patients (Achromobacter
xylosoxidans (P12, 5 clones), H. influenzae (P14,
5 clones), Staphylococcus aureus (P1, 1 clone),
Stenotrophomonas maltophilia (P1, 4 clones) and
Streptococcus intermedius/constellatus part of the
Streptococcus milleri group (P10, 1 clone)). In total,
these represented less than 0.75% of the total
abundance. No taxa from the B. cepacia complex
were recorded in any individual from the patient
cohort.
In the current study, only strict anaerobes were
classed as anaerobes, whereas aerobes, facultative
anaerobes and microaerophiles were classed as
aerobes (Table 2). In agreement with previous
studies (for example, Rogers et al., 2004; Tunney
et al., 2008), we also found strict anaerobic taxa to be
diverse and abundant within the CF airways
(Figure 3). That is, of the 82 taxa observed in the
CF bacterial metacommunity, 38 were strict anae-
robes. These anaerobic taxa were widely distributed
throughout both the core and satellite groups,
accounting for 15.2 and 5.4% of the total abundance,
respectively. In terms of richness, the anaerobes
within the core group were represented by 4 genera
and 10 taxa (Catonella, Porphyromonas, Prevotella
and Veillonella), and within the satellite group by 16
genera and 28 taxa (Figure 3 and Table 2). The
colonisation and persistence of anaerobic taxa could
be explained by the recent observations that oxygen
gradients occur in CF lung mucus and proliferation
of P. aeruginosa within the mucus can generate
anaerobic conditions (Yoon et al., 2002; Tunney
et al., 2008). Although anaerobic taxa have been
implicated in the CF lung and their presence within
the CF airways can be explained, their role in
infection and inflammation needs to be further
elucidated (Rogers et al., 2004).
It has been suggested that the oral cavity can serve
as a pathogen reservoir for a variety of respiratory
infections (Scannapieco, 1999). Previously, a number
of species, normally associated with the oral cavity
30
20
10
0
12 8 4 16 >16
12 8 4 16 >16
12 8 4 16 >16
6
4
2
0
30
20
10
0
F
r
e
q
u
e
n
c
y
Abundance
Figure 2 The abundance distributions for the bacterial meta-
community for (a) all taxa, (b) core taxa best predicted by the log-
normal model (w
2(4)¼2.71; P¼0.607) and (c) satellite taxa best
predicted by the log-series model (w
2(4)¼4.61; P¼0.330). The
frequency of each log2 abundance class predicted by the log-
normal and -series models is shown as a dot.
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The ISME Journalenvironment, have been identified in CF sputum
samples (Rogers et al., 2004, 2006). Through their
presence in well-controlled studies, it is clear
that these oral-associated species are not simply
contaminants. In addition, Rogers et al. (2006)
concluded that the oral cavity acts as both a
reservoir and a ‘stepping stone’ for bacterial immi-
gration into the CF lung. Our findings add support
to that study, as bacterial taxa associated with the
oral cavity were widely distributed across the
empirical SAD and accounted for over 72% of
the overall bacterial diversity observed (Figure 3;
Table 2). This included 24 anaerobic and 35 aerobic
bacterial taxa, and accounted for 18 and 7.9% of the
total abundance, respectively. Within the core
group, ‘oral’ bacterial taxa were dominant in terms
of richness (6 genera and 14 taxa (Table 2)) but
comprised only 20.6% of the abundance within that
group (Figure 3). Again, for the satellite group, ‘oral’
bacterial taxa comprised over 67% of the richness
(20 genera, 45 taxa) and over 75% of the abundance
within that group. But being randomly distributed
and rare within the metacommunity, each taxon was
detected only in less than two different patients
(mean¼1.4 patients±0.8). What is evident is that
bacteria can immigrate from the oral environment,
and colonise and persist within the lower airways of
CF patients. Although this is an important finding,
from a clinical viewpoint, much still remains to be
determined about their role in respiratory disease
within CF patients.
A growing number of studies have observed that
bacterial community composition is highly variable
between CF patients (Rogers et al., 2005; Harris
et al., 2007; Kelpac-Ceraj et al., 2010). Here, similari-
ties and differences in the composition of CF
bacterial communities were assayed using the
Bray–Curtis quantitative index of similarity (SBC);
dendrograms were generated for an average linkage
cluster analysis of profiles from all taxa, and the core
and satellite groups (Figure 4). The resulting cluster
analyses for all taxa also revealed that community
composition was highly variable between patients.
The mean similarity of the bacterial communities
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Figure 3 The richness and abundance of (a) aerobic and anaerobic bacteria and (b) oral microbiota within the whole metacommunity,
the core group and the satellite group. Also given are the actual values of taxa richness and abundance (number of clones). Shaded areas
represent percentage abundance of Pseudomonas aeruginosa within the whole metacommunity and the core group of bacterial taxa.
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The ISME Journaltaken pair-wise was 0.56, with a s.d. of ±0.24
(n¼91 pair-wise comparisons) (Figure 4). When we
examined compositional similarities and differences
for members of core and satellite groups between
patients, we found that similarity was more con-
served for the core group (mean SBC¼0.61±0.25)
than in the satellite group, which comprised rarer
spatially random distributed taxa (SBC¼0.02±0.06).
The presence and abundance of P. aeruginosa
also affected the similarity between patients. When
P1, in whom this taxon was not present, was
removed from the analyses, the mean similarity
of core group members between patients increased
to SBC¼0.70±0.14 (n¼78 pair-wise comparisons).
In the salivary microbiota, it has been established
that there is a high bacterial diversity, within and
between individuals, whereby each person typically
has a unique set of normal oral bacterial species
(Nasidze et al., 2009). In the current study, we found
that members of the oral cavity environment
dominated the diversity of the CF metacommunity
(Figure 3). Therefore, we re-assessed similarity in
community composition between patients with and
without the oral cavity taxa. When the oral micro-
biota members were removed from the analyses, the
mean similarity of bacterial communities between
patients increased to SBC¼0.80±0.03. Conversely,
the composition of the oral microbiota between
patients was highly variable, with a mean similarity
of SBC¼0.16±0.17. This would suggest that coloni-
sation of the CF lungs by bacterial taxa from the oral
cavity strongly influences the high variability
observed between CF lung bacterial communities.
To examine which clinical factors influenced the
composition of all taxa, and the core and satellite
group members between patients, we employed
Mantel and partial Mantel tests. Both CFTR geno-
type and recent antibiotic treatment were found
to correlate with the composition of all taxa and the
core group members across patients, but not with
the satellite group (Table 3). No other clinical factors
such as similarities in lung function (forced expi-
ratory volume in 1s), patient age, gender or steroid
treatment correlated with similarities in composi-
tion (Mantel tests P40.05 in all cases). Finding no
significant correlations between clinical factors and
Table 3 Mantel and partial Mantel test summary statistics
Mantel Partial Mantel
r(SA) P r(SG) P r(SA.G) P r(SG.A) P
Whole community 0.516 0.0001*  0.294 0.003* 0.509 0.0001*  0.278 0.008*
Core group 0.504 0.0001*  0.350 0.001* 0.499 0.0001*  0.343 0.002*
Satellite group  0.255 0.994 0.077 0.763  0.249 0.992 0.050 0.687
The partial Mantel statistic r(SA.G) estimates the correlation between S (community similarity) and A (similarity in antibiotic treatments), while
controlling for the effect of G (differences in CF genotype). Conversely, r(SG.A) estimates the correlation between S and G, while controlling for A.
Mantel test statistics to examine the correlation between S and A or G, respectively, are given. The P-values have been calculated using the
distribution of the partial Mantel or Mantel test statistic estimated from 9999 permutations. Asterisks denote those relationships that were
significant at the Po0.05 level.
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Figure 4 Dendrograms of bacterial community composition in
the 14 patients for (a) all taxa, (b) the core and (c) satellite taxa
groups. Patient taxa profiles were compared using the Bray–Curtis
quantitative index of similarity and average linkage clustering.
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not surprising, as the satellite species are a result of
random dispersal into the CF airways of a given
patient. Using partial Mantel tests, we found that
both CFTR genotype and antibiotic treatment were
still significantly correlated with the composition of
all taxa and the core group members between
patients when controlling for the effects of the other
respective clinical factor (Table 3). Importantly,
antibiotic treatment and CFTR genotype were not
auto-correlated when the Mantel test was performed
(r(AG)¼ 0.111, P¼0.304). This could suggest that
both similarities in CFTR genotype and antibiotic
treatment between the adult patients sampled select
for similar bacterial communities and specifically
for members of the core taxa group.
We also investigated which clinical factors corre-
lated with bacterial taxa richness across the patient
cohort (Figure 5). We found that only lung function
measured by forced expiratory volume in 1s
significantly correlated with richness, demonstrat-
ing significant positive linear relationships for total
taxa richness, and the core and satellite group
member richness (Figure 5), whereby taxa richness
decreased with a reduction in lung function. More
research is needed to be able to explain this
observation, particularly given the fact that forced
expiratory volume in 1s is the single best predictor
of mortality and is an important determinant of
the timing of transplantation (Kerem et al., 1992;
Doershuk and Stern, 1999; Oikonomou et al., 2002).
In addition, however, our findings agree, in part,
with those of the study by Kelpac-Ceraj et al. (2010)
on paediatric CF patients, in that we also found that
similarities in community composition correlated
with similarities in CFTR genotype and antibiotic
treatments. However, we did not find a relationship
between patient age and richness. We postulate that
this may be a result of bacterial community
composition and richness being highly dynamic in
younger patients, and that these community dyna-
mics may stabilise with increase in patients’ age.
In conclusion, this work suggests that for adult
patients, a division can be made in terms of the
species detected into those that are core or satellite
to the CF lung. This has important implications for
subsequent studies, and particularly those involving
deep sequencing. Through this study, however,
certain species were identified as core. Although
any species present in the CF airways may be
important, the identification of such core species
should direct at least the initial focus of research.
Of the species identified as core, only P. aeruginosa
has been regarded traditionally as a key CF patho-
gen. It is worth noting that the other species that
were regarded as traditional CF pathogens were
found here to be transient. However, this study also
identified 10 species within 4 genera associated
previously with the oral cavity as important; all
known pathogens in other infectious contexts. The
importance of this was emphasised by the impact
of removing the satellite species on the overall levels
of similarity observed. In addition, factors such as
CFTR genotype and antibiotic use correlated across
patients with the composition of the core group
members but not with the satellite group. Combined,
this reinforces the need to understand the behaviour
of these species, both singly and in combination, in
relation to CF lung disease. Clearly, more research is
needed to understand the clinical relevance of these
findings. Using the approach employed here, a large
multi-centre study has been initiated, including
patients representing a broader range of CF respira-
tory disease. As such, the present study should act
as a focus for debate over the best ways to interpret
clinically relevant information using ecological
tools. Already, this work has generated fresh insight
into the bacterial communities within the CF lung,
and contributes to the efforts to further improve
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Figure 5 The relationships between bacterial taxa richness and
lung function (FEV1 in litres) for (a) the whole metacommunity,
(b) the core group and (c) the satellite group. In each case linear
regression lines have been fitted. For the whole metacommunity,
r
2¼0.43, F1,12¼9.2, Po0.01; core group, r
2¼0.40, F1,12¼7.82,
Po0.02; and satellite group, r
2¼0.42, F1,12¼8.67, Po0.01.
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The ISME Journaltherapy. This work also strongly supports the notion
that the application of ecological approaches may
similarly provide fresh insights into many other
clinical scenarios.
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